← Leaderboards
Kit N Simpson
Medical University Of South Carolina
$499,923
Attributed
$999,845
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $500K · FY2021–22$500K$375K$250K$125K$0
'21
'22
Funding mix
By agency
AHRQ$999,845 · 2
By mechanism
R01$999,845 · 1
P01$0 · 1
Top collaborators
- Jillian Beree Harvey1 shared
- Kathryn L King1 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Gary S. Gilkeson$15,374,032
- W Timothy Garvey$15,668,226
- Diane L Kamen$6,427,107
- Cynthia F. Wright$11,018,594
- Kathleen Theresa Brady$137,017,915
Others in their field
Top investigators on “African American”
- Daniel C Ralph · Cornell University$89,901,072
- Roger T Howe · University Of California-Berkeley$89,901,072
- James D Crapo · University Of Colorado Denver$80,593,932
- Laurence H Baker · University Of Michigan At Ann Arbor$80,299,268
- William J. Blot · Vanderbilt University$71,101,682
- Sid E O'Bryant · University Of North Texas Hlth Sci Ctr$70,204,880
Research focus
African AmericanClinical ResearchHealth Care Service UtilizationHealth Science Research Analysis /EvaluationHealth Services Research TagHiv InfectionsHuman SubjectMedicare /MedicaidPrimary Care PhysicianQuality Of LifeRural Area
Grant awards (5)
Leveraging Health System Telehealth and Informatics Infrastructure to Create a Continuum of Services for COVID-19 Screening, Testing, and Treatment: A Learning Health System Approach$499,884
R01 · FY2022 · HS · contact PI
Leveraging Health System Telehealth and Informatics Infrastructure to Create a Continuum of Services for COVID-19 Screening, Testing, and Treatment: A Learning Health System Approach$499,961
R01 · FY2021 · HS · contact PI
Economic access to antiretroviral prescription drugs$0
P01 · FY2002 · HS
Economic access to antiretroviral prescription drugs$0
P01 · FY2001 · HS
Economic access to antiretroviral prescription drugs$0
P01 · FY2000 · HS